Literature DB >> 20040046

Recent advances in Hepatitis E virus.

X J Meng1.   

Abstract

Hepatitis E virus (HEV), the causative agent of hepatitis E, belongs to the family Hepeviridae. At least four major genotypes of HEV have been recognized: genotypes 1 and 2 are restricted to humans and associated with epidemics in developing countries, whereas genotypes 3 and 4 are zoonotic and infect humans and several other animals in both developing and industrialized countries. Besides humans, strains of HEV have been genetically identified from swine, chickens, sika deer, mongeese, and rabbits. The genome of HEV consists of three open reading frames (ORFs): ORF1 codes for nonstructural proteins, ORF2 codes for capsid protein, and ORF3 codes for a small multifunctional protein. The ORF2 and ORF3 proteins are translated from a single bicistronic mRNA and overlap each other but neither overlaps ORF1. The recent determination of the 3D crystal structure of the HEV capsid protein should facilitate the development of vaccines and antivirals. The identification and characterization of animal strains of HEV from pigs and chickens and the demonstrated ability of cross-species infection by swine HEV raise public health concerns for zoonosis. Accumulating evidence indicated that hepatitis E is a zoonotic disease and pigs and more likely other animal species are reservoirs for HEV. This article provides an overview of the recent advances in hepatitis E and its causative agent, including nomenclature and genomic organization, gene expression and functions, 3D structure of the virions, changing perspectives on higher mortality during pregnancy and chronic hepatitis E, animal reservoirs, zoonotic risk, food safety, and novel animal models.

Entities:  

Mesh:

Year:  2009        PMID: 20040046     DOI: 10.1111/j.1365-2893.2009.01257.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  73 in total

1.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Cross-species infection of pigs with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States.

Authors:  Caitlin M Cossaboom; Laura Córdoba; Brenton J Sanford; Pablo Piñeyro; Scott P Kenney; Barbara A Dryman; Youchun Wang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-04-25       Impact factor: 3.891

3.  Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.

Authors:  Dong Yang; Mei Jiang; Min Jin; Zhigang Qiu; Weihong Cui; Zhiqiang Shen; Bo Li; Lianfeng Gong; Zhaoli Chen; Xinwei Wang; Jun-Wen Li
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

4.  Enhancement of interferon induction by ORF3 product of hepatitis E virus.

Authors:  Yuchen Nan; Zexu Ma; Rong Wang; Ying Yu; Harilakshmi Kannan; Brenda Fredericksen; Yan-Jin Zhang
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  Hepatitis E Virus in Surface Water, Sediments, and Pork Products Marketed in Southern Brazil.

Authors:  F H Heldt; R Staggmeier; J S Gularte; M Demoliner; A Henzel; F R Spilki
Journal:  Food Environ Virol       Date:  2016-05-12       Impact factor: 2.778

Review 6.  Hepatitis E virus: An ancient hidden enemy in Latin America.

Authors:  Nora A Fierro; Mauricio Realpe; Tzintli Meraz-Medina; Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

7.  Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.

Authors:  M Rapicetta; R Monarca; L A Kondili; P Chionne; E Madonna; G Madeddu; A Soddu; A Candido; S Carbonara; M S Mura; G Starnini; S Babudieri
Journal:  Infection       Date:  2012-12-22       Impact factor: 3.553

8.  Serological evidence for a hepatitis e virus-related agent in goats in the United States.

Authors:  B J Sanford; S U Emerson; R H Purcell; R E Engle; B A Dryman; T E Cecere; V Buechner-Maxwell; D P Sponenberg; X J Meng
Journal:  Transbound Emerg Dis       Date:  2012-08-22       Impact factor: 5.005

9.  Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.

Authors:  Brenton J Sanford; Tanja Opriessnig; Scott P Kenney; Barbara A Dryman; Laura Córdoba; Xiang-Jin Meng
Journal:  Vaccine       Date:  2012-08-17       Impact factor: 3.641

10.  A dual vaccine candidate against norovirus and hepatitis E virus.

Authors:  Leyi Wang; Dianjun Cao; Chao Wei; Xiang-Jin Meng; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2013-11-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.